The Senior Director, Immunology Early Development Strategy & External Innovation, is a senior scientific and development leader within the Immunology Development Unit, reporting directly to the Vice President, Head of Immunology Early Development Innovation and Strategy. The role serves as a close strategic partner and delegate to the Vice President, with accountability for a Immunology portfolio priorities spanning research-to-development transitions, early clinical development strategy, external innovation, and business development and venture investing assessments. This leader will connect scientific insight, clinical development judgment, and enterprise strategy to help Biogen identify, shape, and advance differentiated opportunities for patients with immune-mediated diseases. The position is designed for an accomplished bridge builder who earns trust through expertise, judgment, clarity, and follow-through. Success will depend on the ability to align stakeholders, frame consequential choices, and enable cross-functional teams toward high-quality decisions and execution. The role will work closely with Research, Biomarkers, Clinical Pharmacology, Regulatory, Biostatistics, Clinical Operations, Product Development & Commercialization, Global Commercial, Corporate Strategy, Business Development and External Innovation, and partner companies. Depending on portfolio needs, the Executive Director may lead selected programs or strategic initiatives from preclinical development through proof of biology or proof of concept and contribute to later-stage development planning.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree